IGHE and Increased total eosinophil count: Early case reports using this antibody therapeutically demonstrated reduced exacerbations and improved lung function in CF-ABPA patients with eosinophilia, elevated total serum IgE, and elevated Aspergillus-specific IgE [64,65,66,67], but larger retrospective studies did not find such efficacy [68,69].